These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6876765)

  • 1. Serological study for presence of C-reactive protein, rheumatoid factor, anti streptolysin O in leprosy cases.
    Bhatia VN; Balakrishnan S; Harikrishnan S
    Lepr India; 1983 Jan; 55(1):86-90. PubMed ID: 6876765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
    Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and histological discrepancies in diagnosis of ENL reactions classified by assessment of acute phase proteins SAA and CRP.
    Hussain R; Lucas SB; Kifayet A; Jamil S; Raynes J; Uqaili Z; Dockrell HM; Chiang TJ; McAdam KP
    Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):222-30. PubMed ID: 7602217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid-factor-like substance and antistreptolysin O antibody in leprosy serum. Significance in erythema nodosum leprosum.
    Abe M; Chinone S; Hirako T
    Int J Lepr Other Mycobact Dis; 1967; 35(3):336-44. PubMed ID: 4195462
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological assessment of sera of leprosy patients.
    Sengupta U; Sinha S; Ramu G
    Lepr India; 1979 Jan; 51(1):43-8. PubMed ID: 449283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
    Foss NT; de Oliveira EB; Silva CL
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
    Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy.
    Ridley MJ; Ridley DS; De Beer FC; Pepys MB
    Clin Exp Immunol; 1984 Jun; 56(3):545-52. PubMed ID: 6378453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-1-antitrypsin in leprosy.
    Deshpande SV; Zawar PB; Chawhan RN; Sengupta SR; Mehta MC
    Indian J Lepr; 1985; 57(4):767-72. PubMed ID: 3938987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL).
    Jain VK; Verma KC; Aggarwal SS
    Lepr India; 1983 Jan; 55(1):95-9. PubMed ID: 6876766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference by rheumatoid factor with the detection of C-reactive protein by the latex agglutination method.
    Deyo RA; Pope RM; Persellin RH
    J Rheumatol; 1980; 7(3):279-87. PubMed ID: 7401063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Re-evaluation of tests for CRP, RA, and ASO].
    Tsubokura T; Kawamura K
    Rinsho Byori; 1982 Jul; 30(7):718-24. PubMed ID: 7176119
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum immunoglobulins an autoantibodies during and after erythema nodosum leprosum (ENL).
    Sharma VK; Saha K; Sehgal VN
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):159-63. PubMed ID: 6811448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased level of urinary nitric oxide metabolites in leprosy patients during type 2 reactions and decreased after antireactional therapy.
    Mohanty KK; Gupta M; Girdhar BK; Girdhar A; Chakma JK; Sengupta U
    Lepr Rev; 2007 Dec; 78(4):386-90. PubMed ID: 18309713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
    Kifayet A; Hussain R
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in lepromatous leprosy.
    Ochieng NA; Bwire MS; Orege PA; Nyawalo JO; K'Omollo JW
    Afr J Health Sci; 1994 May; 1(2):79-83. PubMed ID: 12153365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lymphocytotoxic activity in leprosy.
    Rasheed FN; Locniskar M; McCloskey DJ; Hasan RS; Chiang TJ; Rose P; de Soldenhoff R; Festenstein H; McAdam KP
    Clin Exp Immunol; 1989 Jun; 76(3):391-7. PubMed ID: 2752595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of serologic abnormalities in lepromatous leprosy.
    Malaviya AN; Pasricha A; Pasricha JS; Mehta JS
    Int J Lepr Other Mycobact Dis; 1972; 40(4):361-5. PubMed ID: 4202461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.